ID16421A - Gen-gen sintetik - Google Patents

Gen-gen sintetik

Info

Publication number
ID16421A
ID16421A IDP971236A ID971236A ID16421A ID 16421 A ID16421 A ID 16421A ID P971236 A IDP971236 A ID P971236A ID 971236 A ID971236 A ID 971236A ID 16421 A ID16421 A ID 16421A
Authority
ID
Indonesia
Prior art keywords
synthetic genes
genes
synthetic
Prior art date
Application number
IDP971236A
Other languages
English (en)
Inventor
Hakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Sarnstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9601422A external-priority patent/SE9601422D0/xx
Priority claimed from SE9603469A external-priority patent/SE9603469D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID16421A publication Critical patent/ID16421A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDP971236A 1996-04-12 1997-04-14 Gen-gen sintetik ID16421A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601422A SE9601422D0 (sv) 1996-04-12 1996-04-12 Synthetic genes
SE9603469A SE9603469D0 (sv) 1996-09-23 1996-09-23 Synthetic genes

Publications (1)

Publication Number Publication Date
ID16421A true ID16421A (id) 1997-09-25

Family

ID=26662584

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971236A ID16421A (id) 1996-04-12 1997-04-14 Gen-gen sintetik

Country Status (7)

Country Link
EP (1) EP0923604A1 (id)
JP (1) JP2000508898A (id)
AR (1) AR006641A1 (id)
AU (1) AU2417597A (id)
CA (1) CA2250707A1 (id)
ID (1) ID16421A (id)
WO (1) WO1997039023A1 (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
WO1999019347A1 (en) * 1997-10-10 1999-04-22 Astrazeneca Ab Synthetic genes with immunomodulatory effects
GB0524884D0 (en) * 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds
CN115636870B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-缬-亮-亮肽及制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971952A (en) * 1986-03-06 1990-11-20 Collagen Corporation Method of treating inflammation with cartilage inducing factor
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
JPH01501939A (ja) * 1987-01-28 1989-07-06 オーソ・フアーマシユーチカル・コーポレーシヨン 免疫抑制ペプチドおよび使用法
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
CA2008534A1 (en) * 1989-01-26 1990-07-26 Donald E. Ingber Method for inhibiting tumor recurrence after surgical resection
JPH04505325A (ja) * 1989-05-17 1992-09-17 オンコジーン・サイエンス・インコーポレーテツド 組織誘導性腫瘍増殖阻止剤及びその調製方法と使用法
DK0629213T3 (da) * 1992-03-07 1996-11-18 Morinaga Milk Industry Co Ltd Anvendelse af et immunstimulerende middel
JPH08502244A (ja) * 1992-08-11 1996-03-12 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫調節ペプチド
US6696061B1 (en) * 1992-08-11 2004-02-24 President And Fellows Of Harvard College Immunomodulatory peptides
JPH08503694A (ja) * 1992-09-08 1996-04-23 セントコー・インコーポレーテッド ペプチド系の細胞接着阻害物質
US5510332A (en) * 1994-07-07 1996-04-23 Texas Biotechnology Corporation Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor
SE9403526D0 (sv) * 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) * 1995-03-24 1995-03-24 Astra Ab New peptides

Also Published As

Publication number Publication date
AR006641A1 (es) 1999-09-08
WO1997039023A1 (en) 1997-10-23
AU2417597A (en) 1997-11-07
EP0923604A1 (en) 1999-06-23
CA2250707A1 (en) 1997-10-23
JP2000508898A (ja) 2000-07-18

Similar Documents

Publication Publication Date Title
DE69739832D1 (de) Nähfadenankeranordnung
DE69736584D1 (de) Benutzereingabeabtastvorrichtung
DE69739032D1 (de) Bandfixiervorrichtung
DK0948486T3 (da) Pesticid-1-arylpyrazoler
DE69728590D1 (de) Inspektionsgeraet
ID16021A (id) Gen-gen hiv sintetis
DE69713707D1 (de) Multiformatabtastumsetzung
ID19474A (id) Turunan tiazola
DE69709668D1 (de) Viskositätsindexverbesserungsdispergiermittel
ATE208773T1 (de) Chinoxalindione
ID18095A (id) Turunan tetrahidrokinolin
DE69726302D1 (de) Busschnittstellensteuerungsschaltung
DE69735077D1 (de) Spreizspektrumübertragungsgerät
DE69729809D1 (de) Cyclopentanbutanolderivate
DE69722729D1 (de) Reibschweissgerät
DE69713891D1 (de) Polymerentgasung
DE69711505D1 (de) Kohlerhydratderivate
DE69717377D1 (de) Sprachgeschwindigkeitsumwandler
DE69738044D1 (de) Füllkontrollvorrichtung
DE69713362D1 (de) Originalitaetsverschluss
ID16013A (id) PEROLEHAN ε-KAPROLAKTAM
ID16421A (id) Gen-gen sintetik
DE69716524D1 (de) Crimpsteckverbindungsbuchse
DE59712231D1 (de) Flaschenaufsatzdispenser
DE59707895D1 (de) Polyformamide